Caffeine for the management of apnea in preterm infants.
Considerable uncertainty persists regarding the efficacy and safety of methylxanthines (caffeine, theophylline - in intravenous form named aminophylline) for the prevention and treatment of infant apnea. To help inform national guideline development in Kenya we undertook structured literature search...
Main Authors: | Mueni, E, Opiyo, N, English, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2009
|
Similar Items
-
Caffeine in preterm infants: Where are we in 2020?
by: Moschino, L, et al.
Published: (2020) -
Caffeine in preterm infants: where are we in 2020?
by: Laura Moschino, et al.
Published: (2020-03-01) -
Serum caffeine concentrations in preterm infants: a retrospective study
by: Masashiro Sugino, et al.
Published: (2023-06-01) -
Discharging Preterm Infants Home on Caffeine, a Single Center Experience
by: Cheng Ma, et al.
Published: (2020-08-01) -
Early High-Dose Caffeine Improves Respiratory Outcomes in Preterm Infants
by: Vineet Lamba, et al.
Published: (2021-06-01)